Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07534657 · ClinicalTrials.gov registry record · Phase 1
A Study of JPH034 in Healthy Adult Participants
A Phase 1 study, sponsored by J-Pharma Co..
- Recruiting
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT07534657 is a Phase 1 study that is actively recruiting participants, run by J-Pharma Co.. The registered enrollment target is 40 participants.
The verdict
NCT07534657, a Phase 1 study, is actively recruiting participants, sponsored by J-Pharma Co..
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study is designed to evaluate the safety, tolerability, and PK of JPH034 and identify side effects that occur in healthy participants between the ages of 18 and 50 years. Participants enrolling in the trial will be randomly assigned to receive JPH034 or placebo. Participants in the in single-ascending dose (SAD) cohorts will receive treatment once, and one group of participants will receive treatment a second time to study the effects of food. Health measurements including physical examinations, vital signs, ECGs, and safety laboratory tests will be performed to monitor safety. Blood tests will be performed to measure how much JPH034 and its major metabolite (M1) gets into the bloodstream and how long it stays in the body.
Interventions
- OTHER Placebo Control
- DRUG JPH034
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-03-22 |
| Est. Completion | 2026-10-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07534657
The ClinicalTrials.gov registry entry for NCT07534657 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is J-Pharma Co., which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Control is the first listed.
NCT07534657 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07534657 about?
NCT07534657 is a clinical study titled "A Study of JPH034 in Healthy Adult Participants". This study is designed to evaluate the safety, tolerability, and PK of JPH034 and identify side effects that occur in healthy participants between the ages of 18 and 50 years. Participants enrolling in the trial will be randomly assigned to receive JPH034 or placebo. Participants in the in single-as...
What is the current status of trial NCT07534657?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2026-03-22. Estimated completion is 2026-10-10.
What interventions are being tested in trial NCT07534657?
The interventions under investigation include: Placebo Control (OTHER), JPH034 (DRUG).
Who is sponsoring clinical trial NCT07534657?
This trial is sponsored by J-Pharma Co., which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.